Clinical Trial Update: Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin to prevent a new breast cancer in women at high risk; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-06-25